Fig. 1.From: Digital health technologies and Alzheimer’s disease clinical trials: might decentralized clinical trials increase participation by people with cognitive impairment?Trials designs in Alzheimer's disease. A comparison of conventional and DCT designs in AD, with recommendations for optimizing research processes. AD, Alzheimer’s disease; AE, adverse event; APOE, apolipoprotein E; ECG, electrocardiogram; FDG-PET, fluorodeoxyglucose positron emission tomography; MRI, magnetic resonance imagingBack to article page